Skip to main content
. 2020 Oct 31;9(11):2389. doi: 10.3390/cells9112389

Table 3.

Responses by RECIST 1.1 and age group in patients treated with high-dose ifosfamide.

All
(n = 51)
n (%)
<18 yrs
(n = 21)
n (%)
≥18 yrs
(n = 30)
n (%)
p
CR
PR
10 (20) 6 (28) 4 (13) 0.186
SD 29 (57) 10 (48) 19 (63)
PD 12 (23) 5 (24) 7 (23)

CR: complete response; PR: partial response; SD: stable disease; PD: progression of the disease.